Procopio M, Magro G, Cesario F, Piovesan A, Pia A, Molineri N, Borretta G
Division of Endocrinology, Az OspedalieraS. Croce e Carle, Cuneo, Italy.
Diabet Med. 2002 Nov;19(11):958-61. doi: 10.1046/j.1464-5491.2002.00809.x.
To evaluate the frequency of impaired glucose tolerance (IGT)and undiagnosed diabetes mellitus together with the indices of insulin resistance (IR) in primary hyperparathyroidism (pHPT).
Out of 105 consecutive pHPT patients (F/M 78/27, asymptomatic/symptomatic 68/37, age (mean +/- s.d.) 60.7 +/- 12.7 years,body mass index 25.2 +/- 3.8 kg/m2, ionized calcium (iCa) 1.49 +/- 0.16 mmol/l,parathormone 200.4 +/- 233.9 pg/ml),59 without known diabetes mellitus and controls (n = 60) underwent an oral glucose tolerance test (OGTT, 75 g os). As indices of IR, homeostasis model assessment (HOMAIR)or OGTT data (insulin sensitivity index composite (ISI comp)) were evaluated.
In pHPT the prevalence of IGT (mean, 95% confidence intervals (CI), 40.7%, 27.8-53.6) was higher than in controls (25.0%, 13.7-36.3, P < 0.03). Similarly,the prevalence of undiagnosed diabetes mellitus was higher in pHPT(15.3%, 5.8-24.7) than in controls (5.0%, 0-10.7, P < 0.05). Moreover,the prevalence of IGT and undiagnosed diabetes was higher in pHPT than that previously reported in the general population of Northern Italy(8.5% and 3.2%, respectively). The indices showed that insulin resistance was higher in pHPT than in controls: HOMAIR (median, 95% CI,2.6, 2.5-3.9 vs. 1.7, 1.6-2.5, respectively; P < 0.003); ISI comp (3.5, 3.4-4.6 vs. 5.1, 4.9-7.2, respectively; P < 0.002).
Our data in a large and modern day pHPT series, with a preponderance of asymptomatic patients, confirm increased insulin resistance and pre-valence of IGT and undiagnosed diabetes.
评估原发性甲状旁腺功能亢进症(pHPT)患者中糖耐量受损(IGT)及未诊断糖尿病的发生率,以及胰岛素抵抗(IR)指标。
连续纳入105例pHPT患者(女性/男性为78/27,无症状/有症状者为68/37,年龄(均值±标准差)为60.7±12.7岁,体重指数为25.2±3.8kg/m2,离子钙(iCa)为1.49±0.16mmol/L,甲状旁腺激素为200.4±233.9pg/ml),其中59例无已知糖尿病,这些患者及对照组(n = 60)接受了口服葡萄糖耐量试验(OGTT,75g口服)。作为IR指标,评估了稳态模型评估(HOMAIR)或OGTT数据(胰岛素敏感性指数综合值(ISI comp))。
在pHPT患者中,IGT的患病率(均值,95%置信区间(CI),40.7%,27.8 - 53.6)高于对照组(25.0%,13.7 - 36.3,P < 0.03)。同样,pHPT患者中未诊断糖尿病的患病率(15.3%,5.8 - 24.7)高于对照组(5.0%,0 - 10.7,P < 0.05)。此外,pHPT患者中IGT和未诊断糖尿病的患病率高于意大利北部普通人群先前报道的患病率(分别为8.5%和3.2%)。指标显示,pHPT患者的胰岛素抵抗高于对照组:HOMAIR(中位数,95%CI,分别为2.6,2.5 - 3.9与1.7,1.6 - 2.5;P < 0.003);ISI comp(分别为3.5,3.4 - 4.6与5.1,4.9 - 7.2;P < 0.002)。
我们在一个包含大量无症状患者的现代pHPT队列中的数据证实,胰岛素抵抗增加,IGT及未诊断糖尿病的患病率升高。